Experimental drug targets psoriasis and heart risks in one shot
NCT ID NCT04776629
First seen May 19, 2026 · Last updated May 21, 2026 · Updated 1 time
Summary
This study tested a drug called orticumab in 77 adults with moderate-to-severe psoriasis who also had heart disease risk factors like obesity and high cholesterol. The goal was to see if the drug could safely improve skin symptoms and reduce inflammation. Participants received either orticumab or a placebo, and researchers measured changes in psoriasis severity over 15 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Blue Coast Research Center
Vista, California, 92083, United States
-
CCT Research - Springville Dermatology
Springville, Utah, 84663, United States
-
CCT- Research at the center for Dermatology and Plastic Surgery
Scottsdale, Arizona, 85260, United States
-
Center for Clinical Studies, LTD.LLP
Webster, Texas, 77598, United States
-
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250, United States
-
Derm Institute & Skin Care Ctr., Inc.
Santa Monica, California, 90404, United States
-
Excel Clinical Research
Las Vegas, Nevada, 89109, United States
-
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216, United States
-
Las Vegas Clinical Trials
Las Vegas, Nevada, 89030, United States
-
Orange County Research Center
Tustin, California, 92780, United States
-
SMS Clinical Research
Mesquite, Texas, 75149, United States
-
Texas Dermatology and Laser Specialists
San Antonio, Texas, 78218, United States
-
Vital Prospects Clinical Research Institute, PC
Tulsa, Oklahoma, 85260, United States
Conditions
Explore the condition pages connected to this study.